Pulse Biosciences, Inc (HAM:6L8) Financings

Pulse Biosciences, Inc

Financings

RaiseDate
At-the-market programme of common stock
Tranche closed: US$95.8M raised
Nov 5, 2026
At-the-market programme of common stock
Announced: US$75M
Use of proceeds: Financing flexibility through key clinical and regulatory milestones
Aug 6, 2026
At-the-market programme of common stock
Tranche closed: US$10.7M raised
Aug 6, 2026
Common stock on exercise of warrants
Closed: US$1.8M raised
Aug 6, 2026
Warrant exercise of 150% common stock warrants
Announced: US$11 a share
Dec 23, 2024
Warrant exercise of warrants exercised for common stock
Closed: US$58.4M raised
Buyers: Robert W. Duggan (exercised all warrants, corresponding to $58.4 million and 5,306,156 shares)
Insiders: Co-Chairman and majority shareholder Robert W. Duggan exercised all of the warrants he acquired in the 2024 rights offering
Dec 19, 2024

Read by 6ix AI from the company's releases